U.S. Rep. Dan Crenshaw (left), R-Texas, hosted his third annual Healthcare Innovation Summit July 23 at Rice University's BioScience Research Collaborative (BRC) in conjunction with the university's Institute of Biosciences and Bioengineering.
Researchers at Rice University and Baylor College of Medicine develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.
Rice's Educational and Research Initiatives for Collaborative Health has announced six seed grants for research collaborations between faculty from Rice and the Texas Medical Center.
Rice computer scientists are sending RAMBO to rescue genomic researchers who sometimes wait days or weeks for search results from enormous DNA databases.
Rice University bioengineers collaborated on a six-year study that systematically analyzed how the surface architecture of silicone breast implants influences adverse side effects.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Researchers at Rice University and the University of Idaho helped identify a protein that senses and binds to formaldehyde to tell cells that toxic formaldehyde is building up.
Rice University neurobiologist Rosa Uribe has won a five-year, $2 million R01 grant from the National Institutes of Health to study how the enteric nervous system develops.
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
Researchers from Rice University and Baylor College of Medicine are part of a national effort to accelerate genome-editing research and develop gene-editing technologies and therapies.
Rice and Houston Methodist are partnering to solve clinical problems with neurorobotics at the new Center for Translational Neural Prosthetics and Interfaces, a collaboration that brings together scientists, clinicians, engineers and surgeons.
A mutation that replaces a single amino acid in a potent tumor-suppressing protein makes it prone to nucleating amyloid fibrils implicated in many cancers as well as neurological diseases.